Status:
UNKNOWN
Molecular Basis of PCOS in Oocytes and Surrounding Cells
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-37 years
Brief Summary
Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age that is characterized by elevated androgen levels, ovulatory dysfunction and polycystic ovarian morphology (PCOM). Mo...
Eligibility Criteria
Inclusion
- women between the ages of 18 and 37
- biochemical hyperandrogenism
- ovulatory dysfunction
- polycystic ovaries)
- BMI \> 25.
- normal andro-gen levels
- normal ovarian function
- normal ovarian morphology
- BMI \< 29.
Exclusion
- congenital adrenal hyperplasia
- Cushing's syndrome
- androgenic-secreting tumor
- high (\>grade 2) grade endometriosis
- major uterine or ovarian abnormalities
- pregnant women
- volunteers with metabolic syndrome
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04493788
Start Date
July 1 2020
End Date
July 1 2022
Last Update
August 3 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.